Literature DB >> 10210873

Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study.

.   

Abstract

The accuracy of the clinical diagnosis of postencephalitic parkinsonism (PEP) is unknown. We determined the validity of the clinical diagnosis of PEP by presenting 105 records with neuropathologic diagnoses of PEP (n = 7), progressive supranuclear palsy (n = 24), Parkinson's disease (n = 15), dementia with Lewy bodies (n = 14), multiple system atrophy (n = 16), corticobasal degeneration (n = 10), Creutzfeldt-Jakob disease (n = 4), and other dementia disorders (n = 15), as clinical vignettes to six neurologists unaware of the autopsy findings. The neurologists' own clinical diagnoses were compared with neuropathologic diagnoses for measures of diagnostic accuracy, including reliability (kappa statistics), sensitivity and positive predictive values for the first and last visits. The group reliability for the diagnosis of PEP was almost perfect (kappa = 0.91, 0.9). The mean sensitivity at the first visit was 86% (range, 71-100%) with minimal change at the last visit (83%; range, 71-100%). Positive predictive values remained unchanged (100%). The high reliability, sensitivity and positive predictive values of the clinical diagnosis of PEP indicate that neurologists identify this disorder even when they report that they have never evaluated a case. In our data set, the best predictors for the diagnosis of PEP included onset below middle age; symptom duration lasting more than 10 years, and the presence of oculogyric crisis. History of encephalitis lethargica, present in most PEP cases, was an important individual diagnostic predictor. Copyright 1998 Lippincott Williams & Wilkins

Entities:  

Year:  1998        PMID: 10210873     DOI: 10.1046/j.1468-1331.1998.550451.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

Review 1.  The relationship between encephalitis lethargica and influenza: a critical analysis.

Authors:  Sherman McCall; Joel A Vilensky; Sid Gilman; Jeffery K Taubenberger
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

2.  A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

Authors:  James Y Garbern; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee; Gerald Feldman; Joy W Norris; Michael J Friez; Charles E Schwartz; Roger Stevenson; Anders A F Sima
Journal:  Brain       Date:  2010-04-15       Impact factor: 13.501

3.  The diagnosis of postencephalitic parkinsonism at the neurological unit of Boston City Hospital, 1930-1981.

Authors:  Joel A Vilensky; Roger C Duvosin; Sid Gilman
Journal:  Neurol Sci       Date:  2011-02-16       Impact factor: 3.307

4.  Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Authors:  Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal:  Eur J Neurosci       Date:  2016-12-27       Impact factor: 3.386

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.